PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(3)
To Prospectus Dated July 31, 1997, Registration No. 333-31973
As Supplemented to Date
1,657,560 Shares
PHYMATRIX CORP.
Common Stock
This Prospectus Supplement (the "Supplement") relates to up to 13,789
shares (the "Shares") of Common Stock, par value $.01 per share, of PhyMatrix
Corp., a Delaware corporation (the "Company"), which may be offered and sold by
Gary A. Ludi (the "Selling Stockholders") pursuant to the Company's Registration
Statement on Form S-3 (No. 333-31973) (the "Registration Statement"). This
Supplement should be read in conjunction with the Prospectus dated July 31,
1997, which is a part of the Registration Statement, as such Prospectus may have
been supplemented to date (the "Prospectus"). A copy of the Prospectus
accompanies this Supplement. All capitalized terms used but not defined in this
Supplement shall have the meanings given them in the Prospectus.
The Shares were acquired by the Selling Shareholders under the terms of the
Company's acquisition on July 1, 1996 of the assets of Georgia Surgical
Associates, P.C. (the "Practice"), of which the Selling Shareholders were the
sole stockholders. To the Company's knowledge, the Shares which may be offered
represent all the shares of Common Stock owned by the Selling Stockholders. If
all of such Shares are sold, none of the Selling Stockholders will hold any
shares of Common Stock of the Company.
The closing price of the Company's Common Stock as reported on The Nasdaq
National Market on August 13, 1997 was $12.9375 per share.
The date of this Prospectus Supplement is August 14, 1997.
